Medical/Pharmaceuticals
Lipidor AB (publ) Formalizes Relationship With Subsidiary Emollivet AB Through License Agreement and Proposes Financing of Subsidiary
STOCKHOLM, Sweden, July 1, 2020 /PRNewswire/ -- Lipidor AB ("Lipidor" or the " Company") and its subsidiary Emollivet AB ("Emollivet") have formalized the relationship by entering into a licence agreement that regulates the right to Lipidor's patented AKVANO® technology. OnJune 30, Emollivet's Ext...
2020-07-01 08:06
1743
FDA Approves BAVENCIO as First-Line Maintenance Treatment for Patients with Locally Advanced or Metastatic Urothelial Carcinoma
DARMSTADT, Germany and NEW YORK, July 1, 2020 /PRNewswire/ -- Merck and Pfizer Inc. (NYSE: PFE) today announced that the US Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for BAVENCIO® (avelumab) for the maintenance treatment of patients with...
2020-07-01 07:30
7761
Almost Half of Children Are Not Always Using Soap When Washing Hands at School, New Survey by the Global Hygiene Council Finds
Leading hygiene experts are stressing the importance of effective hand hygiene measures and education in schools as children begin returning to educational settings following the COVID-19 pandemic LONDON, July 1, 2020 /PRNewswire/ -- The calls follow a new global survey conducted by The Global H...
2020-07-01 07:01
2724
Carmine Therapeutics and Takeda Collaborate to Discover and Develop Rare Disease Gene Therapies Using Novel Red Blood Cell Extracellular Vesicles Platform
CAMBRIDGE, Mass., July 1, 2020 /PRNewswire/ -- Carmine Therapeutics announced today that it has signed a research collaboration agreement with Takeda Pharmaceutical Company Limited ("Takeda") to discover, develop and commercialize transformative non-viral gene therapies for two rare disease targ...
2020-07-01 07:00
2677
Janssen Korea Ltd. and Johnson & Johnson Innovation Announce Launch of Seoul Innovation QuickFire Challenge for Healthcare in the New Normal in Collaboration with Seoul Metropolitan Government and Korea Health Industry Development Institute
- QuickFire Challenge calls on innovators to identify and accelerate potential solutions aiming to improve patient care in our post-COVID world. - Awardees will receive up to KRW150,000,000 (approximately US $125,000)[1], residence at the Seoul Bio Hub, and mentorship and coaching from experts at...
2020-07-01 05:30
2686
AGC Biologics Expands Development Capacities for pDNA Services at Heidelberg Site
Expansion will help meet the growing demand for plasmid DNA offerings SEATTLE, June 30, 2020 /PRNewswire/ -- Committed to continuous innovation and expansion of its service offerings, AGC Biologics has announced the expansion of its pDNA Center of Excellence in Heidelberg, Germany. The global bi...
2020-06-30 21:00
2348
Ajinomoto Bio-Pharma Services Introduces AJILITY Fast Track Platform for Drug Product Manufacturing
SAN DIEGO, June 30, 2020 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce the launch of AJILITY™, a flexible and agile drug product manufacturing platform, designed to ...
2020-06-30 20:10
1553
One Drop Commended by Frost & Sullivan for Its Industry-leading Connected Glucose Meter and Smartphone Application
SANTA CLARA, California, June 30, 2020 /PRNewswire/ -- Based on its recent analysis of the North American diabetes data management platform market, Frost & Sullivan recognizesOne Drop with the 2020 North America Technology Innovation Leadership Award. One Drop's complete diabetes management platf...
2020-06-30 20:00
1762
Zhejiang Hisun Pharmaceutical: COVID-19 Pandemic Brought Under Control in China With Favipiravir Showing Excellent Clinical Results
TAIZHOU, China, June 30, 2020 /PRNewswire/ -- COVID-19 has become a global pandemic.China's successful control of the pandemic has set a good example for other countries. Many have followedChina to take effective measures like enforcing lockdowns and wearing masks have all been proved to be effec...
2020-06-30 18:51
2468
Release of Initial Attana Virus Analytics-AVA Testing Protocols
STOCKHOLM, June 30, 2020 /PRNewswire/ -- Attana has today released the initial technical protocols for AVA Antibody Testing and will make these available to all existing Attana customers. In close collaboration with Linnaeus University Attana application specialists have been performing studies ...
2020-06-30 15:42
1263
'Curing Cancer without Surgery'
* "Successful disappearance of tumors in subjects upon administering the pain-free anticancer drug, Polytaxel, without side effects such as weight loss." * Suppressed 99.8% of tumors despite a non-toxic dose…more effective than existing FDA-approved pancreatic cancer drugs. * Hopes for a Kore...
2020-06-30 15:10
1512
Sweeping Workplace Changes Expected in a Post-pandemic World, Says Research From The Adecco Group
ZURICH, June 30, 2020 /PRNewswire/ -- * Workers demand greater flexibility after coronavirus, with a 50/50 split of remote and office time confirmed as the universal ideal * Questions raised over the hours-based contract, with 69% saying contracts should be based on results delivered rather t...
2020-06-30 15:00
3083
Thrombosis Research Institute (TRI) Announce ETHIC Trial to Evaluate the Potential Benefits of Early Administration of LMWH in Patients with COVID-19
- Clinical trial will recruit approximately 1400 patients in 10 countries starting in July - Participants will be randomised to receive the low molecular weight Heparin enoxaparin or current standard of care for up to 3 weeks from the time of diagnosis - The study is supported through an inve...
2020-06-30 14:00
1814
AOBiome Reports Successful Clinical Trials (Phase 2a in Adults and Phase 1b in Pediatrics) in Pruritus (Itch) Associated with Atopic Dermatitis: Initiates Phase 2b Clinical Trial in Adults
AOBiome's 576 patient Phase 2b trial commences patient enrollment CAMBRIDGE, Massachusetts, June 30, 2020 /PRNewswire/ -- AOBiome Therapeutics, Inc. ("AOBiome"), a leading clinical-stage microbiome company focusing on inflammation, announced initiation of a Phase2b clinical trial in pruritus (i...
2020-06-30 13:00
1151
Alterity Therapeutics meeting with US FDA provides development pathway for ATH434
MELBOURNE, Australia and SAN FRANCISCO, June 29, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") is pleased to announce that it has received guidance from the US Food and Drug Administration (FDA) in relation to the development pathway for ATH434 ...
2020-06-30 11:14
5988
MedAlliance Gains CE Mark Approval for Coronary SELUTION SLR™ Sirolimus Drug Eluting Balloon
NYON, Switzerland, June 30, 2020 /PRNewswire/ -- MedAlliance has announced the award of its second CE Mark: SELUTION SLR™ 014 PTCA, a novel Sirolimus Drug Eluting Balloon (DEB), for the treatment of coronary arterial disease. This includes indications for both de-novo lesions as well as in-stent ...
2020-06-30 08:00
2231
Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2020
Added 18,488 New Subscribers in 4Q20 4Q20 Revenues Increased by 19.2% YoY to RMB299.9 Million ($42.4 Million) 4Q20 Operating Income Increased by 68.1% YoY to RMB149.3 Million ($21.1 Million) Non-GAAP Operating Income Up 58.7% YoY to RMB161.7 Million ($22.8 Million) Conference Call to be Held on Jun...
2020-06-30 04:16
13648
RevImmune Announces Phase II Trial of the T-Cell Growth Factor CYT107 for COVID-19
Under Way in Europe Since May, In Preparation in the U.S. Designated As An Urgent Public Health National Priority In U.K. BETHESDA, Maryland, June 29, 2020 /PRNewswire/ -- RevImmune, a privately held biotechnology company developing CYT107 immune therapy for infectious diseases and cancer, an...
2020-06-29 21:00
2457
How to Recognize Side-Effects from Immunotherapy? New NCCN Guidelines for Patients can Help
PLYMOUTH MEETING, Pennsylvania, June 29, 2020 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) today announced the publication of new NCCN Guidelines for Patients®: Immunotherapy Side Effects--Immune Checkpoint Inhibitors. Over the past decade, immunotherapy--a treatment that h...
2020-06-29 20:47
2649
Wealth sharing campaign spreading in Suncheon to aid coronavirus victims
SUNCHEON, South Korea, June 29, 2020 /PRNewswire/ -- A wealth sharing campaign
has been spreading in Suncheon, a city about 415 kilometers south ofSeoul, to
support underprivileged citizens hit hard by the coronavirus outbreak.
According to the municipality of Suncheon saidon Friday.
2020-06-29 14:58
3383
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
8288
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
7685